Skip to main content
. 2022 May 7;32(4):291–298. doi: 10.4103/ijn.IJN_21_21

Table 1.

AKI in COVID

All (n=111) Discharged (n=53) In-hospital mortality (n=58) P
AKI
 Stage 1 20 (18%) 13 (25%) 7 (12%) 0.139
 Stage 2 16 (14%) 9 (17%) 7 (12%)
 Stage 3 75 (68%) 31 (58%) 44 (76%)
 Need for RRT 45 (40.5%) 15 (28.3%) 30 (50%) 0.022
 AKI on CKD 23 (20.7%) 13 (24.5%) 10 (17%) 0.360
Duration of RRT (days)
 <4 22 (49%) 1 (7%) 21 (70%) <0.001
 5-9 16 (35.5%) 9 (60%) 7 (23%)
 >10 7 (15.5%) 5 (34%) 2 (7%)
Renal recovery at discharge
 Complete 31 (28%) 31 (58%) 0 <0.001
 Partial 20 (18%) 20 (38%) 0
 No recovery 2 (2%) 2 (4%) 0
 Expired 58 (52%) 0 58 (100%)
Renal Recovery at 3 months
 Recovered 23 (20.7%) 23 (43%) 0
 CKD Progression 26 (23.4%) 26 (49%) 0
 Expired 62 (55.85%) 4 (8%) 58 (100%)

AKI=acute kidney injury; RRT=renal replacement therapy; CKD=chronic kidney disease. P value less than 0.5 is considered significant and has been highlighted in bold